Notice: Images are for illustration only and may not reflect the exact product you receive. Brand-name medications may look different depending on their country of origin—Canadian versions, for example, often include a "PR" symbol on the packaging. Rest assured, the medication, dosage, and active ingredients will be exactly as prescribed. Canada Pharmacy Store is committed to your health and safety, and we work only with licensed pharmacies to ensure you receive trusted, high-quality medication every time.
General Medication Fact Sheet for Samsca
Missed DoseTake as soon as you remember; skip if it’s almost time for your next dose. Do not double the dose.
| Field | Information |
|---|---|
| Medication Name | Samsca |
| Generic Name | Tolvaptan |
| Boxed/Label Warning | Must be initiated and re-initiated in a hospital and monitor serum sodium. Too rapid correction of hyponatremia can cause serious neurologic sequelae. Not recommended for patients who urgently need to raise serum sodium. |
| Purpose | Treatment of clinically significant hypervolemic and euvolemic hyponatremia (low sodium levels) |
| Mechanism of Action | Selective vasopressin V2-receptor antagonist in the kidneys, promoting excretion of water without significant sodium loss |
| Dosage Forms | Oral tablets |
| Available Strengths | 15 mg, 30 mg |
| Dosage Frequency | Once daily |
| Common Side Effects | Thirst, dry mouth, frequent urination, weakness, constipation |
| Serious Side Effects | Rapid correction of hyponatremia, liver injury, dehydration, hyperkalemia (high potassium) |
| Drug Interactions | Strong CYP3A4 inhibitors (e.g., ketoconazole, clarithromycin), strong CYP3A4 inducers (e.g., rifampin), digoxin, diuretics |
| Important Notes | Initiation and re-initiation of therapy should occur in a hospital setting; monitor serum sodium levels; avoid fluid restriction |
| Storage | Store at room temperature away from moisture and light |
| Alternatives | Fluid restriction, intravenous saline solutions (for severe cases), conivaptan |
Samsca Alternatives
| Medication | Mechanism of Action | Notes |
|---|---|---|
| Fluid Restriction | Limits water intake | First-line treatment for mild hyponatremia. |
| Intravenous Saline Solutions | Increases sodium levels in the blood | Used for severe or symptomatic hyponatremia in a hospital setting. |
| Conivaptan (Vaprisol) | Vasopressin V1A and V2-receptor antagonist | Another vasopressin antagonist; administered intravenously. |
Samsca Side Effects
| Common Side Effects | Serious Side Effects |
|---|---|
| Thirst | Rapid correction of hyponatremia (Osmotic Demyelination Syndrome) |
| Dry mouth | Liver injury |
| Frequent urination | Dehydration |
| Weakness | Hyperkalemia (high potassium levels) |
| Constipation | Kidney problems |
Samsca Dosage Guide
| Condition | Starting Dose | Maintenance Dose | Administration Notes |
|---|---|---|---|
| Hypervolemic or Euvolemic Hyponatremia | 15 mg once daily | 15 mg to 60 mg once daily (titrated based on serum sodium levels) | Initiate and re-initiate in a hospital. Monitor sodium levels closely. |
